T. Rowe Price Associates’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-42,136
| Closed | -$639K | – | 2598 |
|
|
2019
Q4 | $639K | Buy |
42,136
+1,886
| +5% | +$16.3K | ﹤0.01% | 2069 |
|
|
2019
Q3 | $257K | Buy |
40,250
+282
| +0.7% | +$2.35K | ﹤0.01% | 2337 |
|
|
2019
Q2 | $382K | Buy |
39,968
+338
| +0.9% | +$3.64K | ﹤0.01% | 2224 |
|
|
2019
Q1 | $537K | Buy |
39,630
+900
| +2% | +$7.5K | ﹤0.01% | 2087 |
|
|
2018
Q4 | $278K | Sell |
38,730
-13,041
| -25% | -$143K | ﹤0.01% | 2319 |
|
|
2018
Q3 | $564K | Buy |
51,771
+17,298
| +50% | +$174K | ﹤0.01% | 2107 |
|
|
2018
Q2 | $317K | Sell |
34,473
-316,554
| -90% | -$2.95M | ﹤0.01% | 2328 |
|
|
2018
Q1 | $2.81M | Sell |
351,027
-2,178,007
| -86% | -$47.4M | ﹤0.01% | 1504 |
|
|
2017
Q4 | $70.3M | Buy |
2,529,034
+122,666
| +5% | +$3.25M | 0.01% | 749 |
|
|
2017
Q3 | $65M | Buy |
2,406,368
+10,457
| +0.4% | +$274K | 0.01% | 752 |
|
|
2017
Q2 | $69.8M | Buy |
2,395,911
+345,934
| +17% | +$10.5M | 0.01% | 714 |
|
|
2017
Q1 | $69.9M | Buy |
+2,049,977
| New | +$66.1M | 0.01% | 699 |
|
|
2016
Q3 | – | Sell |
-17,347
| Closed | -$507K | – | 2577 |
|
|
2016
Q2 | $507K | Sell |
17,347
-76,623
| -82% | -$2.11M | ﹤0.01% | 1962 |
|
|
2016
Q1 | $1.94M | Buy |
+93,970
| New | +$2.31M | ﹤0.01% | 1529 |
|
T. Rowe Price Associates's DERM Position: Q1 2020 in Review
T. Rowe Price Associates sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 42,136 shares — an estimated $639K sold.
T. Rowe Price Associates first reported a position in DERM in Q1 2016 and held it in 14 quarters. The position peaked at $70.3M in Q4 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- T. Rowe Price Associates reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- T. Rowe Price Associates sold 42,136 Dermira, Inc. shares in Q1 2020, an estimated $639K.
- T. Rowe Price Associates first reported a position in Dermira, Inc. in Q1 2016 and held it in 14 quarters.
- T. Rowe Price Associates's Dermira, Inc. position peaked at $70.3M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.